Cite
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.
MLA
Lee, S. M., et al. “Comparison of Gemcitabine and Carboplatin versus Cisplatin and Etoposide for Patients with Poor-Prognosis Small Cell Lung Cancer.” Thorax, vol. 64, no. 1, Jan. 2009, pp. 75–80. EBSCOhost, https://doi.org/10.1136/thx.2007.093872.
APA
Lee, S. M., James, L. E., Qian, W., Spiro, S., Eisen, T., Gower, N. H., Ferry, D. R., Gilligan, D., Harper, P. G., Prendiville, J., Hocking, M., & Rudd, R. M. (2009). Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax, 64(1), 75–80. https://doi.org/10.1136/thx.2007.093872
Chicago
Lee, S. M., L. E. James, W. Qian, S. Spiro, T. Eisen, N. H. Gower, D. R. Ferry, et al. 2009. “Comparison of Gemcitabine and Carboplatin versus Cisplatin and Etoposide for Patients with Poor-Prognosis Small Cell Lung Cancer.” Thorax 64 (1): 75–80. doi:10.1136/thx.2007.093872.